Top Companies and Competitive Dynamics in the Temporary Mechanical Circulatory Support Device Market

The temporary mechanical circulatory support device market is positioned for substantial expansion in the coming years, driven by innovations and growing clinical demand. As new technologies emerge and healthcare settings evolve, this sector is set to experience notable advancements and increased adoption worldwide.

Expected Expansion in the Temporary Mechanical Circulatory Support Device Market by 2030
The temporary mechanical circulatory support device market is projected to reach a value of $4.1 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.0%. This anticipated growth is fueled by advancements in biomimetic and hybrid devices, a rising preference for minimally invasive mechanical circulatory support (MCS), increasing volumes of cardiac surgeries, widening outpatient cardiac care centers, and the integration of digital monitoring alongside smart hemodynamic management systems. Key trends expected to shape the market include greater uptake of percutaneous ventricular assist devices, more frequent use of extracorporeal membrane oxygenation (ECMO), expansion in high-risk cardiac interventions, and growing applications for bridge-to-transplant and bridge-to-recovery, alongside an emphasis on portable, minimally invasive MCS solutions.

Download a free sample of the temporary mechanical circulatory support device market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27434&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Primary Companies Leading the Temporary Mechanical Circulatory Support Device Industry
The competitive landscape of the temporary mechanical circulatory support device market is dominated by several global players, including Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Getinge AB, LivaNova PLC, Magenta Medical Ltd., CorWave SA, Procyrion Inc., CardioBridge GmbH, Abiomed Inc., Berlin Heart GmbH, Thoratec Corporation, PulseCath BV, TandemLife Inc., SynCardia Systems LLC, CardiacAssist Inc., Xenios AG, Nihon Kohden Corporation, Eurosets Srl, Senko Medical Instrument Manufacturing Co Ltd, Nipro Medical Corporation, Calon Cardio-Technology Ltd., and Windmill Cardiovascular Systems Inc.

Significant Acquisition Enhancing Abbott Laboratories' Portfolio
In February 2023, Abbott Laboratories, a US-based pharmaceutical giant, acquired Cardiovascular Systems, Inc. (CSI), a medical device firm specializing in temporary mechanical circulatory support devices. Though the financial details were not disclosed, this acquisition strengthens Abbott's vascular-device lineup by incorporating CSI's expertise in atherectomy technology. This move aims to bolster treatment options for patients suffering from complex peripheral and coronary artery diseases, expanding Abbott's presence in cardiovascular therapies.

View the full temporary mechanical circulatory support device market report:
https://www.thebusinessresearchcompany.com/report/temporary-mechanical-circulatory-support-device-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Emerging Trends and Collaborations in the Temporary Mechanical Circulatory Support Device Market
Key players in the temporary mechanical circulatory support device sector are actively forging strategic partnerships to push technological boundaries. For example, in November 2025, Australia's VenstraMedical collaborated with US venture capital firm Highcroft Capital to secure funding aimed at accelerating development of its next-generation percutaneous ventricular assist device (pVAD). This compact, catheter-based pump is designed for full ventricular unloading and hemodynamic support in patients experiencing cardiogenic shock or undergoing high-risk coronary procedures. Protected by multiple patents, the device offers minimally invasive insertion and can pump up to 7 liters of blood per minute. This strategic investment reflects VenstraMedical's goal to revolutionize temporary MCS within a market valued above $2 billion, with plans to advance toward clinical trials and commercialization.

Detailed Segmentation of the Global Temporary Mechanical Circulatory Support Device Market
The temporary mechanical circulatory support device market is categorized by type, technology, application, and end user:
1) By Type: Left Ventricular Support Devices, Right Ventricular Support Devices, Biventricular Support Devices
2) By Technology: Pneumatic Devices, Mechanical Pumps, Biomimetic Devices, Hybrid Systems, Novel Wearable Devices
3) By Application: Cardiogenic Shock, Bridge to Transplantation, Bridge to Recovery, High-Risk Cardiac Procedures, Other Uses
4) By End User: Hospitals, Cardiac Surgery Centers, Outpatient Surgical Facilities, Research and Academic Institutions, Other End Users

Additional subcategories include:
- Left Ventricular Support Devices such as Intra-Aortic Balloon Pump, Percutaneous Ventricular Assist Device, and Extracorporeal Membrane Oxygenation
- Right Ventricular Support Devices including Right Ventricular Assist Device, Extracorporeal Membrane Oxygenation, and Percutaneous Right Ventricular Assist Device
- Biventricular Support Devices like Biventricular Assist Device, Temporary Total Artificial Heart, and Extracorporeal Membrane Oxygenation

This comprehensive segmentation provides a clear understanding of the product types, technologies, and end users shaping the market's evolution.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.